Perspective
Published on 01 Nov 2023
Fecal microbiota transplantation—could stool donors’ and receptors’ diet be the key to future success?
in Gastrointestinal Infection
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1270899
- 995 views
Type at least 3 characters
114 articles
Articles
Brief Research Report
Published on 24 Oct 2023
X-ray phase-contrast 3D virtual histology characterises complex tissue architecture in colorectal cancer
in Gastroenterology and Cancer
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1283052
- 978 views
- 2 citations
Editorial
Published on 24 Oct 2023
Editorial: Benefiting from microbes: challenges in getting the ‘pros’ and avoiding the ‘cons’
in Gastrointestinal Infection
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1293448
- 585 views
Original Research
Published on 23 Oct 2023
Adalimumab biosimilar ABP 501 is equally effective and safe in long-term management of inflammatory bowel diseases patients when used as first biologic treatment or as replace of the ADA originator for a non-medical reason
in Therapy in Gastroenterology
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1218228
- 570 views
- 1 citation
Original Research
Published on 18 Oct 2023
A blood-based transcriptomic signature stratifies severe Crohn’s disease and defines potentially targetable therapeutic pathways
in Therapy in Gastroenterology
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1251133
- 843 views
Review
Published on 16 Oct 2023
The potential links between human gut microbiota and cardiovascular health and disease - is there a gut-cardiovascular axis?
in Gastrointestinal Infection
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1235126
- 1,128 views
Case Report
Published on 11 Oct 2023
Case report and narrative review of the literature: a rare colonic stent failure in a palliative patient
in Endoscopy
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1279085
- 654 views
Systematic Review
Published on 10 Oct 2023
Unresectable intrahepatic cholangiocarcinoma: TARE or TACE, which one to choose?
in Gastroenterology and Cancer
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1270264
- 1,300 views
- 1 citation
Review
Published on 03 Oct 2023
Sex- and gender-related differences in inflammatory bowel diseases
in Therapy in Gastroenterology
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1199687
- 8,022 views
- 1 citation
Review
Published on 03 Oct 2023
Role of peroral cholangioscopy and pancreatoscopy in the diagnosis and treatment of biliary and pancreatic disease: past, present, and future
in Endoscopy
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1201045
- 1,053 views
Mini Review
Published on 19 Sep 2023
Addressing the unmet clinical need for low-volume assays in early diagnosis of pancreatic cancer
in Gastroenterology and Cancer
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1258998
- 936 views
Original Research
Published on 14 Sep 2023
Efficacy and safety of Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 as an adjuvant for Helicobacter pylori eradication: a double-blind, randomized, placebo-controlled study
in Gastrointestinal Infection
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1245993
- 1,775 views
Original Research
Published on 11 Sep 2023
The relations between constipation and characteristics of intestinal morphologies by colonoscopy
in Endoscopy
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1255129
- 599 views
Original Research
Published on 05 Sep 2023
Effects of a sucralfate-containing ointment on quality of life and symptoms associated with hemorrhoidal disease: patient-reported results of a Slovakian, pharmacist-led observational survey
in Endoscopy
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1213433
- 1,624 views
Editorial
Published on 21 Aug 2023
Editorial: Gastrointestinal and bilio-pancreatic stenting: when, which stent and why
in Endoscopy
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1271139
- 408 views
Case Report
Published on 21 Aug 2023
Case Report: Primary small bowel adenocarcinoma with peritoneal metastasis responded well to a CapeOX + bevacizumab regimen
in Gastroenterology and Cancer
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1187194
- 742 views